Shopping Cart 0
Cart Subtotal
USD 0

AstraZeneca UK Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

AstraZeneca UK Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc is a provider of asthma treatment solutions. The company offers research and develops various novel and targeted medicines. It offers its medicines in therapeutic areas which include cardiovascular; oncology, respiratory, inflammation and autoimmunity; neuroscience and infection and vaccines. The company's targeted therapies provide treatment of cardiovascular and metabolic diseases; oncology diseases; respiratory diseases, inflammations; infections and other neuroscience diseases. It operates in Germany, Argentina, Brazil, Canada, Chile, Colombia, India, Japan, China, Norway, Russia, the UAE, the UK and the US, among others. AstraZeneca is headquartered in London, the UK.

AstraZeneca UK Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Bind Therapeutics Enters Into Co-Development Agreement With AstraZeneca For Accurin 10

Asset Transactions 11

Alliance Pharma Acquires Antimalarial Drug Brands From AstraZeneca UK For US$8 Million 11

Acquisition 12

AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 12

AstraZeneca UK Ltd-Key Competitors 14

Key Employees 15

Locations And Subsidiaries 16

Head Office 16

Appendix 17

Methodology 17

About GlobalData 17

Contact Us 17

Disclaimer 17


List Of Figure

List of Figures

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8


List Of Table

List of Tables

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 1

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

AstraZeneca UK Ltd, Deals By Therapy Area, 2011 to YTD 2017 8

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Bind Therapeutics Enters Into Co-Development Agreement With AstraZeneca For Accurin 10

Alliance Pharma Acquires Antimalarial Drug Brands From AstraZeneca UK For US$8 Million 11

AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 12

AstraZeneca UK Ltd, Key Competitors 14

AstraZeneca UK Ltd, Key Employees 15

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

AstraZeneca UK Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc is a provider of asthma treatment solutions. The company offers research and develops various novel and targeted medicines. It offers its medicines in therapeutic areas which include cardiovascular; oncology, respiratory, inflammation and autoimmunity; neuroscience and infection and vaccines. The company's targeted therapies provide treatment of cardiovascular and metabolic diseases; oncology diseases; respiratory diseases, inflammations; infections and other neuroscience diseases. It operates in Germany, Argentina, Brazil, Canada, Chile, Colombia, India, Japan, China, Norway, Russia, the UAE, the UK and the US, among others. AstraZeneca is headquartered in London, the UK.

AstraZeneca UK Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Bind Therapeutics Enters Into Co-Development Agreement With AstraZeneca For Accurin 10

Asset Transactions 11

Alliance Pharma Acquires Antimalarial Drug Brands From AstraZeneca UK For US$8 Million 11

Acquisition 12

AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 12

AstraZeneca UK Ltd-Key Competitors 14

Key Employees 15

Locations And Subsidiaries 16

Head Office 16

Appendix 17

Methodology 17

About GlobalData 17

Contact Us 17

Disclaimer 17


List Of Figure

List of Figures

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8


List Of Table

List of Tables

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 1

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

AstraZeneca UK Ltd, Deals By Therapy Area, 2011 to YTD 2017 8

AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Bind Therapeutics Enters Into Co-Development Agreement With AstraZeneca For Accurin 10

Alliance Pharma Acquires Antimalarial Drug Brands From AstraZeneca UK For US$8 Million 11

AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 12

AstraZeneca UK Ltd, Key Competitors 14

AstraZeneca UK Ltd, Key Employees 15

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS